Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the preliminary efficacy of finite therapy with the combination of GS-4059 and entospletinib with and without obinutuzumab in subjects with relapsed or refractory chronic lymphocytic leukemia (CLL)
Critère d'inclusion
- Adults with relapsed or refractory chronic lymphocytic leukemia